U.S. Markets close in 4 hrs 4 mins
  • S&P 500

    3,285.35
    +4.29 (+0.13%)
     
  • Nasdaq

    10,808.55
    +29.75 (+0.28%)
     
  • Russell 2000

    1,478.81
    -6.44 (-0.43%)
     
  • Crude Oil

    39.53
    +0.22 (+0.56%)
     
  • Gold

    1,902.70
    -7.90 (-0.41%)
     
  • Silver

    24.44
    +0.05 (+0.22%)
     
  • EUR/USD

    1.1705
    -0.0068 (-0.5736%)
     
  • 10-Yr Bond

    0.6760
    +0.0050 (+0.75%)
     
  • Vix

    27.66
    -0.12 (-0.43%)
     
  • GBP/USD

    1.2713
    -0.0104 (-0.8124%)
     
  • BTC-USD

    10,469.71
    +31.98 (+0.31%)
     
  • CMC Crypto 200

    213.30
    -0.46 (-0.21%)
     
  • FTSE 100

    5,829.46
    +25.17 (+0.43%)
     
  • Nikkei 225

    23,360.30
    +40.90 (+0.18%)
     

TelaCare Deploys COVID-19 Self-Assessment Tool with Virtual Doctors Integrated

FISHERS, Ind., March 23, 2020 /PRNewswire/ -- TelaCare, a national telehealth technology, and services company, announced today several actions aimed at combating the spread of the Novel Coronavirus 2019 (COVID-19). Specifically, TelaCare is providing a Coronavirus (COVID-19) assessment tool with direct access to infectious disease doctors through their platform.

"Today's actions, taken together with preventative steps, represent a call to action across the Nation," said TelaCare CEO, Larry Jones. "All Americans must immediately review the CDC's procedures to ensure we gain control of this virus. TelaCare and telemedicine companies Nationwide are experiencing a large spike in virtual care during this epidemic. We must continue working together to keep Americans safe and healthy and prevent the spread of COVID-19. Our goal is everyone's safety and more members we can assist during these times, the better we all are."

"Durning the recent outbreak of COVID-19, TelaCare has been responding by doing what we do best. Technology! said TelaCare CTO, Dennis Peacock. " Our development team has been working diligently over the past week and are pleased to deliver the COVID-19 Update Center and Self-assessment tool with virtual doctors integrated. "

Based on a series of questions and answers consumers that are experiencing signs and symptoms of COVID-19 will be immediately directed to initiate a consultation with one of our network physicians for further evaluation via phone or video.

Members are provided with key CDC resources to assist them with the next steps. Those members that do not show signs or symptoms of COVID-19 will have the most up to date information as it is available to assist them and keep them updated.

Improving access to medical care while containing costs continues to be a crucial driver in the transformation of the healthcare industry. While controversy remains about the most effective ways to do so, one solution on which all parties agree is the importance of incorporating virtual care into any comprehensive healthcare program.

About TelaCare

TelaCare Health Solutions, LLC a Digital Healthcare Technology company has developed a proprietary, HIPAA-compliant telemedicine platform built in the AWS Cloud that allows healthcare providers to consult with patients remotely. Our advanced API technology allows third parties to integrate and offer a customized telemedicine experience to support their brand identity. Physicians can perform on-demand consultations with members anywhere via telephone and video technology. Patients get advice, recommendations and a diagnosis, which may include a prescription for common illnesses.

TelaCare Health Solutions, LLC and TelaCare have registered trademarks in the United States and other countries. All other trademarks used herein are the property of their respective owners. For more information on our services, visit www.TelaCare.com.

To join TelaCare and have a doctor visit now, visit www.telacare.com/signup.

Media Contact:
Faith Jones
800-317-0280
236503@email4pr.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/telacare-deploys-covid-19-self-assessment-tool-with-virtual-doctors-integrated-301028461.html

SOURCE TelaCare